Product / Device

Vitamin E and/or vitamin E derivative-containing product

Overview

Active Ingredient
vitamin E
RxNorm CUI
11256

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

14
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Vitamin E supplementation in people with cystic fibrosis: A Cochrane review summary.
Dru Riddle J · Int J Nurs Stud · 2019
PMID: 29954583Meta-Analysis
The emerging role of immunothrombosis in paediatric conditions.
Franchi Thomas, Eaton Simon, De Coppi Paolo et al. · Pediatr Res · 2019
PMID: 30808021Meta-Analysis
Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review.
Bertola Elena A, Simonetti Giacomo D, Del Giorno Rosaria et al. · Clin Rev Allergy Immunol · 2019
PMID: 31392657Meta-Analysis
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi Laura, Gaiani Federica, Vincenzi Francesca et al. · Acta Biomed · 2018
PMID: 30561409Meta-AnalysisFull text (PMC)
Vitamin E supplementation in people with cystic fibrosis.
Okebukola Peter O, Kansra Sonal, Barrett Joanne · Cochrane Database Syst Rev · 2017
PMID: 28262916Meta-AnalysisFull text (PMC)
Vitamin E supplementation in people with cystic fibrosis.
Okebukola Peter O, Kansra Sonal, Barrett Joanne · Cochrane Database Syst Rev · 2014
PMID: 25489958Meta-Analysis
Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials.
Suksomboon N, Poolsup N, Sinprasert S · J Clin Pharm Ther · 2011
PMID: 21198720Meta-Analysis
Risk of inadequate intakes of vitamins A, B1, B6, C, E, folate, iron and calcium in the Spanish population aged 4 to 18.
Serra-Majem L, Ribas L, Ngo J et al. · Int J Vitam Nutr Res · 2001
PMID: 11840835Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Product / Device
Fully Specified Name
Product containing vitamin E and/or vitamin E derivative (product)
SNOMED CT
63822004
UMLS CUI
C0042874
RxNorm CUI
11256

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
14
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.